It prices the pharmacy, which nobody else here does
The ordinary shape of this category is one price per drug and a pharmacy nobody names. Seventeen of the sixty-five sellers here name a pharmacy at all, and of those, one publishes a separate price for each pharmacy it works with. This is that one.
Six pharmacies carry monthly plans, and the page names them, prints the formulation each prepares, attaches a beyond-use window, and gives every lane its own figure. A reader can see what the choice of pharmacy actually costs, which is a question the rest of this field does not let anyone ask.
Beyond the monthly plans it names more than a dozen further compounding pharmacies across its catalogue. That is the longest such list on this roster by a wide margin, and it is the reason this row exists.
Read the ingredient list, not just the drug name
Seven of the eight monthly lanes are combination preparations. The active GLP-1 is compounded with a vitamin, an amino acid or a related additive, and the product name on the page says so. Only one lane is the plain drug.
That is not a footnote. A compounded semaglutide with an added B vitamin is not the same product as a compounded semaglutide, and neither is the same product as the FDA-approved finished drug. Anyone comparing these figures against a single-ingredient preparation elsewhere is comparing different things.
The dose in each lane also matters. Every figure on this row is the starter tier of its section, and each section's higher doses cost more. The qualifier beside each price names the higher figures in that lane, so you can see the ladder without opening the page.
The prices are real, and they are behind a control
The whole price table sits inside collapsed accordions. On load the page's visible text runs to a few thousand characters and contains no figures at all; after the toggles are opened it runs to more than forty thousand and the table appears.
This site's rule is that visible text is what counts, and a control on the page that reveals a figure makes that figure published. These are published. A reader who does not click, however, sees a pricing page with no prices on it, which is a real usability cost and a real reason people conclude a seller hides its numbers.
One further condition sits at page level: a monthly plan is typically dispensed as a single vial and is intended for use within about five weeks. That is a supply term, and most of this field never states one.
A membership that is scoped to the brand-name lane
The pricing page prints a standard treatment plan at a monthly fee plus the cost of medication, twice, in consecutive lines, one of them naming the brand-name version. Immediately after it says that if you and your provider choose a branded product you will be invoiced for it.
The compounded monthly plans are quoted differently — each as a total for one month's supply, with shipping and supplies included. Both facts are recorded on this row, and neither is used to explain the other away. Twenty of the sixty-five sellers here bill a membership apart from the medication.
The question worth asking before you buy is a short one: does the monthly plan figure for the pharmacy you pick already include everything, or does the standard-plan fee sit underneath it. The page states both structures and does not say which applies to which purchase.
Where the disclosure stops
There is no state list. The seller says why: each pharmacy is licensed to ship to its own set of states, and it points at a separate per-pharmacy coverage page. That is an honest reason, and it still means you cannot tell from the priced page whether you can buy. This roster does not merge per-pharmacy coverage into one array, because subtracting one published number from another invents a fact.
The governing-law clause names no state. It says the terms are governed by the laws of the state applicable to the patient's care, which is not a forum a reader can identify in advance. That is unusual enough to say out loud.
No individual prescribing clinician is named anywhere. The company itself, its address and its privacy and notice documents are published, so the corporate disclosure is fine; it is the clinical one that stops.
Lavender Sky Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $139/moA combination preparation, not plain semaglutide. Verbatim: "Monthly Starter Dose – $139 total for one month supply · Recommended if new to treatment or for doses up to 0.75mg/week", under "Southend Pharmacy - Semaglutide/B6 Injection · Up to 90 days BUD. Shipping and supplies are included." The page adds that Monthly Plans "are typically dispensed as a single vial and are intended for use within five weeks". Higher doses in this lane are $159 and $179. | September 2026source |
| Semaglutide (compounded) | $149/moA semaglutide/B12 combination preparation, priced as a "total for one month supply" and dispensed as a single vial intended for use within five weeks. Higher doses in this lane are $159 and $189. | September 2026source |
| Semaglutide (compounded) | $165/moA semaglutide/glycine/B12 combination preparation, priced as a "total for one month supply". Higher doses in this lane are $180 and $195. | September 2026source |
| Tirzepatide (compounded) | $149/moA tirzepatide/B6 combination preparation, priced as a "total for one month supply". Higher doses in this lane are $169, $189 and $199. | September 2026source |
| Tirzepatide (compounded) | $155/moThe only lane on this page with no co-ingredient — plain tirzepatide — priced as a "total for one month supply". Higher doses in this lane are $179, $195 and $209. | September 2026source |
| Tirzepatide (compounded) | $175/moA tirzepatide/glycine/B12 combination preparation, priced as a "total for one month supply". Higher doses in this lane are $235, $250 and $295. | September 2026source |
| Tirzepatide (compounded) | $189/moA tirzepatide/niacinamide combination preparation, priced as a "total for one month supply". Higher doses in this lane are $225, $225 and $335. | September 2026source |
| Tirzepatide (compounded) | $190/moA tirzepatide/B12 combination preparation, priced as a "total for one month supply". Higher doses in this lane are $205, $225 and $240. | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 65 providers reviewed here are paid partners today; the other 61 are not. See how this works.
See Lavender Sky Health's current price →Good fit if
- Readers who want to know which pharmacy will compound their medication, and what choosing that specific pharmacy costs.
- Buyers who want the co-ingredient printed in the product name so they can tell a combination preparation from a plain one.
- People who want a supply term stated — how the medication is dispensed and how long it is meant to last — rather than only a monthly figure.
- Readers looking for compounded liraglutide, which this seller lists and very few others do.
Look elsewhere if
- Anyone who needs to know their state is served before starting. There is no company-wide list, only a per-pharmacy coverage page.
- Readers who want the plain single-ingredient drug. Seven of the eight monthly lanes here are combination preparations.
- Buyers who want a forum named in the terms. The governing-law clause points at whichever state applies to the patient's care.
- People who want an individual prescribing clinician named before they pay.
How this review was verified
- Opened all fifty-three collapsed sections on the pricing page in a browser before reading any figure, and confirmed that the page's visible text grows from a few thousand characters to more than forty thousand when they are opened. A price census on the unopened page returns nothing.
- Established which pharmacy each price block belongs to three independent ways that agree: the markup's own per-block title, the rendered order after expansion, and the page's own sentence naming which six pharmacies carry monthly plans. Without that third check the mapping would have been an assumption about document order.
- Recorded only the starter lane of each section. The tier and extended lanes state their per-month cost as a range the seller derives by division, and a range is not a price.
- Carried the co-ingredient into the dose field of every row, because a row saying only compounded semaglutide would be describing a different product.
- Recorded the standard-plan monthly fee as a separate membership with the seller's own wording, including that it is stated beside the brand-name plan, rather than merging it into the compounded figures.
- Quoted the seller's own explanation for having no state list rather than recording the absence, and did not merge per-pharmacy coverage into a single list.
- Searched the agency's published warning-letter record for the company name, 2017 to 2026, and found nothing. That search covers warning letters only; untitled letters are published separately and were not searched.
- Noted that the page never reaches a settled network-idle state in an automated browser. Its server behaves normally; the timeout reads like a dead host and is not one.